Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
4304 participants
INTERVENTIONAL
2022-05-12
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT01057888
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT00715234
Adolescent Vaccination Reminder Study
NCT01732315
Study of Adolescent Immunization Recall Systems
NCT01390363
Reducing Delay in Vaccination of Children: Logistic Barriers
NCT03516682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Reminder/recall
Reminder/Recall Sent Via Preferred Method of Communication
Parents of 12-17 year-old patients due for COVID-19 booster dose will receive a one-time vaccine reminder/recall via the parent's preferred method of communication (mailed letter, text message, email)
Usual Care
No Reminder/Recall
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reminder/Recall Sent Via Preferred Method of Communication
Parents of 12-17 year-old patients due for COVID-19 booster dose will receive a one-time vaccine reminder/recall via the parent's preferred method of communication (mailed letter, text message, email)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Due for a COVID-19 booster dose (completed the COVID-19 primary series and it has been ≥5 months since their second dose)
Exclusion Criteria
* Opted out of Marshfield Clinic Health System centralized vaccine reminder notifications
* Received COVID-19 vaccine off label
* Missing or invalid contact information
* Deceased
12 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marshfield Clinic Research Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Huong McLean, PhD
Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Huong McLean, PhD
Role: PRINCIPAL_INVESTIGATOR
Marshfield Clinic Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marshfield Clinic Health System
Marshfield, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCL10517a
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.